Although the identification of mutations in NF-κB regulators in 17% of MM patients shed some light on the mechanisms responsible for the constitutive NF-κB activation, other genetic alterations involved in this pathway are still incompletely understood [7–9]. Here, NFKB1 is linked to Miyoshi myopathy.